Anatomic Pathology Testing Market

direct to customer facility, and government awareness about
early cancer detection and diagnosis are likely to boost the
growth of the anatomic pathology testing market. High cost of
digital imaging, poor resolution, set up costs, lack of depth
perception are some of the factors restraining the market.
Geographically, the anatomic pathology testing market is
dominated by North America due to rising incidence of cancer
and epathology solutions. Rising prevalence of chronic diseases,
rapid increase in geriatric population, and high acceptance of
personalized medicine and digital laboratory propel the market
in Europe. Growing academic and government investment in
diagnostic research and rising awareness about the use of
anatomic pathology test among physicians are projected to boost
the growth of the market in Asia Pacific.
Increasing globalization, sound economy, and changing lifestyle
habits of the population in the region has led to the growth of the
anatomy pathology testing market in Latin America. High life
expectancy, increasing burden of diseases, increasing chronic
and non-communicable diseases such as diabetes, cancer, and
obesity fuel the growth of the anatomic pathology testing
market. Improving living standards, and increasing demand for